Product Information

ELETRIPTAN HBR 20 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.5891 per EA under NDC 59651010469. Its NADAC has been published 353 times since Feb 12, 2020.

FDA first approved this application on Jan 15, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ELETRIPTAN HBR 20 MG TABLET

Eletriptan Hydrobromide
$1.5891per EA

Strength

20 mg/1

NDC

59651010469

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ELETRIPTAN HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210708

FDA Approved

1/15/2019

TE Code

AB

On Market Since

1/15/2019

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for ELETRIPTAN HBR 20 MG TABLET has been published 353 times since Feb 12, 2020, and over the history we have for it it has declined 72.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5891 per EA
All-time high$6.7898 (Apr 13, 2022)
All-time low$1.5891 (Oct 21, 2026)
52-week high$2.2870
52-week low$1.5891
Median price$3.1875
Average price$3.5264
Largest weekly change+67.0% (Mar 23, 2022)
Weeks tracked353
Tracking sinceFeb 12, 2020

Price History

1W

0.0%

1M

-8.1%

3M

-30.5%

6M

-11.8%

1Y

-25.5%

3Y

-50.3%

5Y

-69.4%

All

-72.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ELETRIPTAN HBR 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ELETRIPTAN HBR 20 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.5891 per EA (NDC 59651010469), effective Nov 11, 2026.

How has the price of ELETRIPTAN HBR 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for ELETRIPTAN HBR 20 MG TABLET has declined 72.9%. It has been tracked across 353 weekly CMS publications since Feb 12, 2020.

What are the highest and lowest recorded NADAC prices for ELETRIPTAN HBR 20 MG TABLET?

Since Feb 12, 2020, the NADAC for ELETRIPTAN HBR 20 MG TABLET has ranged from a low of $1.5891 (Oct 21, 2026) to a high of $6.7898 (Apr 13, 2022), with a median of $3.1875 per EA.

Are there cheaper alternatives to ELETRIPTAN HBR 20 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ELETRIPTAN HBR 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ELETRIPTAN HBR 20 MG TABLET?

ELETRIPTAN HBR 20 MG TABLET (NDC 59651010469) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.